Uric Acid: A Biomarker and Pathogenic Factor of Affective Disorders and Neurodegenerative Diseases

被引:0
|
作者
Chu, Teng [1 ]
Liu, Ge [1 ]
Liu, Jing [1 ]
Wu, Yue [1 ]
Fang, Weirong [1 ]
机构
[1] China Pharmaceut Univ, Sch Basic Med Sci & Clin Pharm, State Key Lab Nat Med, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Uric acid; affective disorders; neurodegenerative diseases; inflammation; oxidative stress; autophagy; MAJOR DEPRESSIVE DISORDER; TERM ANTIDEPRESSANT TREATMENT; NF-KAPPA-B; OXIDATIVE STRESS; BIPOLAR DISORDER; PARKINSONS-DISEASE; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; PURINE METABOLISM; MOUSE MODEL;
D O I
10.2174/0113816128333916241003180018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Uric acid (UA), the end-product of purine metabolism, has a complicated physiological role in the body, showing the combination of regulating inflammatory response, promoting oxidation/anti-oxidation, and modifying autophagy activity in vivo. Meanwhile, various research and theories support that inflammation, oxidative stress, and other risk factors promote the onset and progression of affective disorders and neurodegenerative diseases. Existing studies suggest that UA may be involved in the pathophysiological processes of affective disorders in various ways, and there has been a gradual advance in the understanding of the interplay between UA levels and affective disorders and neurodegenerative diseases. This review summarized the role of UA in the process of inflammation, oxidative stress, and autophagy. On this basis, we discussed the correlation between UA and affective disorders and several neurodegenerative diseases, and simultaneously analyzed the possible mechanism of its influence on affective disorders and neurodegenerative diseases, to provide a theoretical basis for UA as a biomarker or therapeutic target for the diagnosis of these diseases.
引用
收藏
页码:585 / 597
页数:13
相关论文
共 50 条
  • [41] The use of proteomics in biomarker discovery in neurodegenerative diseases
    Davidsson, P
    Sjögren, M
    DISEASE MARKERS, 2005, 21 (02) : 81 - 92
  • [42] NEURODEGENERATIVE DISORDERS A biomarker and a target for progressive MS
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (10) : 771 - 771
  • [43] Neurodegenerative disorders and ischemic brain diseases
    Mattson, MP
    Duan, W
    Pedersen, WA
    Culmsee, C
    APOPTOSIS, 2001, 6 (1-2) : 69 - 81
  • [44] Managing sleep disorders in neurodegenerative diseases
    Iranzo, Alex
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (06) : 573 - 576
  • [45] Sleep Disorders Associated with Neurodegenerative Diseases
    Anghel, Lucretia
    Ciubara, Anamaria
    Nechita, Aurel
    Nechita, Luiza
    Manole, Corina
    Baroiu, Liliana
    Ciubara, Alexandru Bogdan
    Musat, Carmina Liana
    DIAGNOSTICS, 2023, 13 (18)
  • [46] Neurodegenerative disorders and ischemic brain diseases
    M. P. Mattson
    W. Duan
    W. A. Pedersen
    C. Culmsee
    Apoptosis, 2001, 6 : 69 - 81
  • [47] Serum uric acid a depression biomarker
    Meng, Xiandong
    Huang, Xia
    Deng, Wei
    Li, Jiping
    Li, Tao
    PLOS ONE, 2020, 15 (03):
  • [48] Affective empathy in neurodegenerative disorders: The importance of measurement type
    Wright, Janet K. X.
    Grainger, Sarah A.
    Coundouris, Sarah P.
    Henry, Julie D.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 127 : 808 - 819
  • [49] Uric acid and cardiometabolic diseases
    Seung Jae Lee
    Byeong Kil Oh
    Ki-Chul Sung
    Clinical Hypertension, 26
  • [50] Uric acid and cardiometabolic diseases
    Lee, Seung Jae
    Oh, Byeong Kil
    Sung, Ki-Chul
    CLINICAL HYPERTENSION, 2020, 26 (01)